The chloromethylketone protease inhibitor AAPFCMK also targets ATP-dependent helicases and SAP-domain proteins

Journal of Cellular Biochemistry

Volumn 100, Issue 3, 2007, Pages 716-726

  Dhamne, Chetan ^a   Drubin, David A ^a   Duncan, Kimberly ^a   Tevethia, M Judith ^b   Clawson, Gary A ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Carcinogenesis; Helicase; HPV; HtrA protease; Nucleus; Protease inhibitor; SAP domain

Indexed keywords

ALANYLALANYLPROLYLPHENYLALANYL CHLOROMETHYL KETONE; COHESIN; DNA; HELICASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA REPAIR; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING; RAT; VIRUS INFECTION; WART VIRUS;

ADENOSINE TRIPHOSPHATE; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA HELICASES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; MASS SPECTROMETRY; OLIGOPEPTIDES; PROTEASE INHIBITORS; RATS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 33846588035     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21021     Document Type: Article

References (63)

1. Abdelhaleem M. 2004. Do human RNA helicases have a role in cancer? Biochim Biophys Acta 1704:37-46.
2. Allinen M, Beroukhim R, Cia L, et al. 2004. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6:17-32.
3. Alonso LG, Garcia-Alai MM, Smal C, et al. 2004. The HPV16 E7 viral oncoprotein self-assembles into defined spherical oligomers. Biochemistry 43:3310-3317.
4. Alonso LG, Smal C, Garcia-Alai MM, et al. 2006. Chaperone holdase activity of human papillomavirus E7 oncoprotein. Biochemistry 45:657-667.
5. Arai Y, Hosoda F, Kobayashi H, et al. 1997. The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene DDX10. Blood 89:3936-3944.
6. Aratani S, Fujii R, Fujita H, et al. 2003. Aromatic residues are required for RNA helicase mediated transactivation. Int J Mol Med 12:175-180.
7. Baldi A, De Luca A, Morini M, et al. 2002. The HtrA1 serine protease is down-regulated during human melanoma progression and represees growth of metastatic melanoma cells. Oncogene 21:6684-6688.
8. Beaber J, Hochnut B, Waldor M. 2004. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427:72-74.
9. Bellanger S, Blachon S, Mechali F, et al. 2005. High-risk, but not low-risk HPV E2 proteins bind to the APC activators Cdh1 and Cdc20 and cause genomic instability. Cell Cycle 4:1608-1615.
10. Beresford PJ, Zhang D, Oh DY, et al. 2001. Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-strand DNA nicks. J Biol Chem 43285-43293.
11. Bernardini M, Lee C, Beheshti B, et al. 2005. High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer. Neoplasia 7:603-613.
12. Bohm F, Kappes F, Scholten I, et al. 2005. The SAF-box domain of chromatin protein DEK. Nucleic Acids Res 33:1101-1110.
13. Budhu AS, Wang XW. 2005. Loading and unloading: Orchestrating centrosome duplication and spindle assembly by Ran/Crm1. Cell Cycle 4:151-1514.
14. Carty S, Greenleaf AS. 2002. Hyperphosphorylated C-terminal repeat domain-associating proteins in the nuclear proteome. Mol Cell Proteomics 1:598-610.
15. Chen XQ, Du X, Liu J, et al. 2004. Identification of genes encoding putative nucleoporins and transort factors i the fission yeast Schizosaccharomyces pombe: A deletion analysis. Yeast 21:495-509.
16. Clausen T, Southan C, Ehrmann M. 2002. The HtrA family of proteases: Implications for protein composition and cell fate. Mol Cell 10:443-455.
17. Clawson G, Norbeck L, Hatem C, Rhodes C, Amiri P, McKerrow J, Patierno S, Fiskum G. 1992. Ca2+-regulated serine protease associated with the nuclear scaffold. Cell Growth Diff 3827-3838.
18. Clawson G, Norbeck L, Wise J, Patierno S. 1993. An inhibitor of nuclear scaffold protease blocks chemical transformation of fibroblasts. Cell Growth Diff 4:589-594.
19. Clawson G, Ren L, Isom H. 1995. Nuclear scaffold-associated protease: In situ nuclear localization and effects of a protease inhibitor on growth and morphology of a ras-transformed hepatocyte cell line. Hepatology 22:1230-1235.
20. Colombo E, Marine JC, Danovi D, Falini B, Pelicci PG. 2002. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 4:529-533.
21. d'Ari R. 1985. The SOS system. Biochimie 67:343-347.
22. Dai Y, Wong B, Yen Y, Oettinger M, Kwon J, Johnson R. 2005. Determinants of HMGB proteins required to promote RAG 1/2-recombination signal sequence complex assembly and ctalysis during V(D)J recombination. Mol Cell Biol 25:4413-4425.
23. De Luca A, De Falco M, Sererino A, Campioni M, Santini D, Baldi F, Paggi MG, Baldi A. 2003. Distribution of the serine protease HtrA1 in normal human tissues. J Histochem Cytochem 51:1279-1284.
24. Doxsey S, McCollon D, Theurkauf W. 2005. Centrosomes in cellular regulation. Annu Rev Cell Dev Biol 21:411-434.
25. Drubin D, Clawson G. 2004. Spontaneous transformation of an immortalized hepatocyte cell line: Potential role of a nuclear protease. Cancer Lett 213:39-48.
26. Drubin D, McLaughlin-Drubin M, Clawson G, Meyers C. 2006. A protease inhibitor specifically inhibitsgrowth of HPV-infected keratinocytes. Mol Ther (in press).
27. Ehrmann M, Clausen T. 2004. Proteolysis as a regulatory mechanism. Annu Rev Genet 38:709-724.
28. Frank E, Ennis D, Gonzalez M, Levine A, Woodgate R. 1996. Regulation of SOS mutagenesis by proteolysis. Proc Natl Acad Sci USA 93:10291-10296.
29. Fukasawa K. 2005. Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230:6-19.
30. Gai D, Li D, Finkielstein CV, Ott RD, Taneja P, Fanning E, Chen XS. 2004. Insights into the oligomeric states, conformational changes, and helicase activities of SV40 large tumor antigen. J Biol Chem 279:38952-38959.
31. Gonzales B, Henning D, So R, Dixon J, Dixon M, Valdez B. 2005. The Treacher Collins syndrome (TCOF1) gene product is involved in pre-rRNA methylation. Hum Mol Genet 11:2035-2043.
32. Goodman M. 2002. Error-prone repair DNA polymerases in prokaryotes and eukaryotes. Annu Rev Biochem 71:17-50.
33. Ikeda T, Ikeda K, Sasaki K, Kawakimi K, Takahara J. 1999. The inv(11)(p15q22) chromosome translocation of therapy-related myelodysplasia results in NUP98-DDX10 and DDX10-NUP98 fusion transcripts. Int J Hematol 69:160-164.
34. Ikegawa S, Isomura M, Koshizuka Y, Nakamura Y. 1999. Cloing and characterization of ASH21 and Ash21, human and mouse homologs of the Drosophila ash2 gene. Cytogenet Cell Genet 84:167-172.
35. Iouk T, Kerscher O, Scott RJ, Basrai MA, Wozniak RW. 2002. The yeast nuclear pore complex functionally interacts with components of the spindle assembly checkpoint. J Cell Biol 159:807-819.
36. Ishiai M, Kimura M, Namikoshi K, Yamazoe M, Yamamoto K, Arakawa H, Agematsu K, Takdea S, Buerstedde JM, Takata M. 2004. DNA cross-link repair protein SNM1A interacts with PIAS1 in nuclear focus formation. Mol Cell Biol 24:10733-10741.
37. Kierszenbaum AL, Gil M, Rivkin E, Tres LL. 2002. Ran, a GTP-binding protein involved in nucleocytoplasmic transport and microtubule nucleation, relocates from the manchette to the centrosome region during rat spermiogenesis. Mol Reprod Dev 63:131-140.
38. Koch P, Bohlmann I, Schafer M, Hansen-Hagge TE, Kivoi H, Wilda M, Hameister H, Bartram CR, Janssen JW. 2000. Iderntification of a novel putative Ran-binding protein and its close homologue. Biochem Biophys Res Commun 278:241-249.
39. Kusano A, Staber C, Chan HY, Ganetzky B. 2003. Closing the (Ran)GAP on segregation distortion in Drosophila. Bioessays 25:108-115.
40. Lusser A, Kadonaga JT. 2003. Chromatin remodeling by ATP-dependent molecular machines. Bioessays 25:1192-1200.
41. Madsen K, Fiskum G, Clawson G. 1990. Regulation of nuclear scaffold protease activity by calcium. Exp Cell Res 187:343-345.
42. Munger K, Duensing S. 2004. Human Papillomavirus infection and centrosome anomalies in cervical cancer In: Nigg E, editor. Centrosomes in development and disease. Weinheim, Germany; Wiley-VCH, pp Chapter 4.3.
43. Nayler L, Stratling W, Bourguin JP, Stagljar I, Lindemann L, Jasper H, Hartmann A, Fackelmayer F, Ullrich A, Stamm S. 1998. SAF-B protein couples transcription and pre-mRNA spliciing to SAR/MAR elements. Nucl Acids Res 26:3542-3549.
44. Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soma A, Kanda H, Matsurmoto M, Kawaichi M. 2004. HtrA1 serine protease inhibits signaling mediated by tgfbeta family proteins. Development 131:1041-1053.
45. Plafker SM, Macara IG. 2002. Ribosomal protein L12 uses a distinct nuclear import pathway mediated by importin 11. Mol. Cell Biol 22:1266-1275.
46. Sadygov R, Cociorva D, Yates J. 2004. Large-scale database searching using tandem mass spectra: Looking up the answer in the back of the book. Nat Methods 1:195-202.
47. Sahara S, Aoto M, Eguchi Y, Imamoto N, Yoneda Y, Tsujimoto Y. 1999. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature 401:168-173.
48. Savitsky K, Ziv Y, Bar-Shira A, Gilad S, Tagle D, Smith S, Uziel T, Sfez S, Nahimias J, Sartiel A, Eddy R, Shows T, Rotman G. 1996. A human gene (DDX10) encoding a putative DEAD-box RNA helicase at 11q22-q23. Genomics 33:199-206.
49. Sharma S, Doherty K, Brush R. 2005. DNA helicases as targets for anticancer drugs. Curr Med Chem 5:183-199.
50. Sluder G. 2005. Two-way traffic: Centrosomes and the cell cycle. Nat Rev Mol Cell Biol 6:743-748.
51. Swanson P. 2004. The bounty of RAGs: Recombination signal complexes and reaction outcomes. Immunol Rev 200:90-114.
52. Ueda T, Shirakawa H, Yoshida M. 2002. Involvement of HMGB1 and HMGB2 proteins in exogenous DNa integration reaction into the genome of HeLa S3 cells. Biochim Biophys Acta 1593:77-84.
53. Uhlmann-Schiffler H, Seinsoth S, Stahl H. 2002. Preformed hexamers of SV40 T antigen are active in RNA and origin-DNA unwinding. Nucl Acids Res 30:3192-3201.
54. Ungureanu D, Vanhatupa S, Kotaja N, Yang J, Aittomaki S, Hanne OA, Palvimo JJ, Silvennoinen O. 2003. PIAS protiens promte SUMO-1 conjugation to STAT1. Blood 102:3311-3313.
55. Valle M, Chen XS, Donate LE, Fanning E, Carazo JM. 2006. Structural basis for the cooerative assembly of large T antigen on the origin of replication. J Mol Biol 357:1295-1305.
56. Varma R, Hector S, Clark K, Greco W, Hawthorn L, Pendyala L. 2005. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10. Oncol Rep 14:925-932.
57. Waldmann T, Scholten I, Kappes F, Hu H, Knippers R. 2004. The DEK protein-an abundant and ubiquitous constituent of mammalian chromatin. Gene 343:1-9.
58. Warner D, Bhattacherjee V, Yin X, Singh S, Mukhopadhyay P, Pisano M, Greene R. 2004. Functional interaction between Smad, CREB binding protein, and p68 RNA helicase. Biochem. Biophys Res Commun 324:70-76.
59. Wintersberger U. 1984. The selective advantage of cancer cells: A consequence of genome mobilization in the course of the induction of DNA repair processes? (Model studies on yeast). Adv Enzyme Reg 22:311-322.
60. Wise-Draper T, Allen H, Thobe M, Jones E, Habash K, Munger K, Wells S. 2005. The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7. J Virol 79:14309-14317.
61. Yamamoto M, Kakihana K, Kurosa T, Murakami N, Miura O. 2005. Clonal evolution with inv(11)(p15q22) and NUP98/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia. Cancer Genet Cytogenet 157:104-108.
62. Zelenaya-Troitskaya O, Newman SM, Okamoto K, Perlman PS, Butow RA. 1998. Functions of the high mobility group protein, Abf2p, in mitochondrial DNA segragation, recombination and copy number in Saccharomyces cerevisiae. Genetics 148:1763-1776.
63. Zhang D, Li M, Ma W, Hou Y, Li YH, Li SW, Sun QY, Wang WH. 2005. Localization of mitotic arrest deficient 1 (MAD1) in mouse oocytes during the first meiosis and its functions as a spindle checkpoint protein. Biol Reprod 72:58-68.